Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda

Timothy R Muwonge, Rogers Nsubuga, Charles Brown, Agnes Nakyanzi, Monica Bagaya, Felix Bambia, Elly Katabira, Peter Kyambadde, Jared M Baeten, Renee Heffron, Connie Celum, Andrew Mujugira, Jessica E Haberer, Timothy R Muwonge, Rogers Nsubuga, Charles Brown, Agnes Nakyanzi, Monica Bagaya, Felix Bambia, Elly Katabira, Peter Kyambadde, Jared M Baeten, Renee Heffron, Connie Celum, Andrew Mujugira, Jessica E Haberer

Abstract

Background: Scale-up of oral pre-exposure prophylaxis (PrEP) for HIV prevention in Uganda began with serodiscordant couples (SDC) and has expanded to other most at-risk populations (MARPs). We explored knowledge, acceptability, barriers and facilitators of PrEP use among potential PrEP users in four MARPs (SDC; men who have sex with men [MSM]; female sex workers [FSW], and fisher folk).

Methods: We administered quantitative surveys to potential PrEP users in multiple settings in Central Uganda at baseline and approximately 9 months after healthcare worker (HCW) training on PrEP.

Results: The survey was completed by 250 potential PrEP users at baseline and 125 after HCW training; 55 completed both surveys. For these 250 participants, mean age was 28.5 years (SD 6.9), 47% were male and 6% were transgender women, with approximately even distribution across MARPs and recruitment locations (urban, peri-urban, and rural). Most (65%) had not heard about PrEP. After HCW training, 24% of those sampled were aware of PrEP, and the proportion of those who accurately described PrEP as "antiretrovirals to be used before HIV exposure" increased from 54% in the baseline survey to 74% in the second survey (p<0.001). The proportion of participants who reported HCW as a source of PrEP information increased after training (59% vs 91%, p<0.001). In both surveys, nearly all participants indicated they were willing to take PrEP if offered. The most common anticipated barriers to PrEP were stigma, transportation, accessibility, busy schedules, and forgetfulness. Closeness to home was a common facilitator for all participant categories.

Conclusions: Initial awareness of PrEP was low, but PrEP knowledge and interest increased among diverse MARPs after HCW training. Demand creation and HCW training will be critical for increasing PrEP awareness among key populations, with support to overcome barriers to PrEP use. These findings should encourage the acceleration of PrEP rollout in Uganda.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Participant flow.
Fig 1. Participant flow.

References

    1. Chou R, Evans C, Hoverman A, Sun C, Dana T, et al. (2019) Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US Preventive Services Task Force. Jama 321: 2214–2230. 10.1001/jama.2019.2591
    1. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’reilly KR, et al. (2016) Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS (London, England) 30: 1973 10.1097/QAD.0000000000001145
    1. Haberer JE (2016) Current concepts for PrEP adherence: In the PrEP revolution; from clinical trials to routine practice. Current Opinion in HIV and AIDS 11: 10 10.1097/COH.0000000000000220
    1. WHO (2018) Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization.
    1. McCormack SM, Noseda V, Molina JM (2016) PrEP in Europe—expectations, opportunities and barriers. J Int AIDS Soc 19: 21103 10.7448/IAS.19.7.21103
    1. Kay ES, Pinto RM (2020) Is Insurance a Barrier to HIV Preexposure Prophylaxis? Clarifying the Issue. Am J Public Health 110: 61–64. 10.2105/AJPH.2019.305389
    1. Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, et al. (2013) High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav 17: 2162–2172. 10.1007/s10461-012-0317-8
    1. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL (2013) From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS 27: 248–254. 10.1089/apc.2012.0419
    1. Reza-Paul S, Lazarus L, Jana S, Ray P, Mugo N, et al. (2019) Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up. Gates Open Research 3 10.12688/gatesopenres.13042.2
    1. MOH (2018) Consolidated Guidelines on the Prevention and Treatment of HIV in Uganda. Kampala, Uganda: Ministry of Health.
    1. Baeten J, Heffron R, Kidoguchi L, Mugo N, Katabira E, et al. (2016) Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1–serodiscordant couples: A prospective implementation study in Kenya and Uganda. PLoS Med 13: e1002099 10.1371/journal.pmed.1002099
    1. Heffron R, Ngure K, Odoyo J, Bulya N, Tindimwebwa E, et al. (2017) Pre-exposure prophylaxis for HIV-negative persons with partners living with HIV: uptake, use, and effectiveness in an open-label demonstration project in East Africa. Gates Open Res 1: 3 10.12688/gatesopenres.12752.2
    1. Minisrty of Health Uganda (2016) Technical Guidance on Pre-Exposure Prophylaxis (PrEP) for Persons at High Risk of HIV in Uganda. In: (MOH) MoH, editor. Kampala, Uganda: Government of Uganda.
    1. Uganda AIDS Commission 2015. National HIV and AIDS Strategic Plan 2015/2016–2019/2020. 2015. Accessed September 5, 2020. Available from: .
    1. Hodges-Mameletzis I, Fonner VA, Dalal S, Mugo N, Msimanga-Radebe B, et al. (2019) Pre-Exposure Prophylaxis for HIV Prevention in Women: Current Status and Future Directions. Drugs 79: 1263–1276. 10.1007/s40265-019-01143-8
    1. Ministry of Health Uganda (2016). Consolidated guidelines for prevention and treatment of HIV in Uganda. Available from . Accessed September 5, 2020.
    1. Djomand G (2020) Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016–September 2018. MMWR Morbidity and Mortality Weekly Report 69 10.15585/mmwr.mm6908a3
    1. Ministry of Health Uganda (2017). Uganda Population-Based HIV Impact Assessment (UPHIA) 2016–2017. MOH; Uganda.
    1. Uganda MoH (2010) National Implementation Guidelines for HIV Counselling and Testing in Uganda. Ministry of Health Uganda.
    1. Timothy RM, Rogers N, Monica B, Timothy S, Elly KPK, Jared M, et al. Health care worker perspectives of PrEP service delivery in central Uganda. 15th International Conference on HIV Treatment and Prevention Adherence (Adherence 2020). November 2–3 (Virtual).
    1. Huang X, Hou J, Song A, Liu X, Yang X, et al. (2018) Efficacy and safety of oral TDF-based pre-exposure prophylaxis for men who have sex with men: A systematic review and meta-analysis. Frontiers in pharmacology 9: 799 10.3389/fphar.2018.00799
    1. Sidebottom D, Ekström AM, Strömdahl S (2018) A systematic review of adherence to oral pre-exposure prophylaxis for HIV–how can we improve uptake and adherence? BMC infectious diseases 18: 581 10.1186/s12879-018-3463-4
    1. de Mendoza C (2019) UNAIDS Update Global HIV Numbers. AIDS reviews 21: 170
    1. President's Emergency Plan for AIDS Relief (PEPFAR). Uganda Country Operational Plan (COP) 2019 Strategic Direction Summary. Available from . 2019. Accessed September 5, 2020.
    1. United States Agency for International Development (2019). Target setting for PrEP. PrEP learning network 2020. Available from . Accessed September 5, 2020.
    1. UNAIDS 2014 Report (2014) Fast-Track—Ending the AIDS epidemic by 2030. Available from . Accessed September 5, 2020.
    1. Koenig LJ, Lyles C, Smith DK (2013) Adherence to antiretroviral medications for HIV pre-exposure prophylaxis: lessons learned from trials and treatment studies. Am J Prev Med 44: S91–98. 10.1016/j.amepre.2012.09.047
    1. Krakower DS, Mayer KH (2016) The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS 11: 41–48. 10.1097/COH.0000000000000206
    1. PEPFAR (2018) Uganda Country Operational Plan (COP) 2018. Strategic Direction Summary. President’s Emergency Plan for AIDS Relief.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit